167 related articles for article (PubMed ID: 29471123)
21. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, properties, and antitumor effects of a new mixed phosphine gold(I) compound in human colon cancer cells.
Lupidi G; Avenali L; Bramucci M; Quassinti L; Pettinari R; Khalife HK; Gali-Muhtasib H; Marchetti F; Pettinari C
J Inorg Biochem; 2013 Jul; 124():78-87. PubMed ID: 23632460
[TBL] [Abstract][Full Text] [Related]
23. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
25. Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds.
Engman L; McNaughton M; Gajewska M; Kumar S; Birmingham A; Powis G
Anticancer Drugs; 2006 Jun; 17(5):539-44. PubMed ID: 16702810
[TBL] [Abstract][Full Text] [Related]
26. Organometallic gold(iii) complexes with hybrid SNS-donating thiosemicarbazone ligands: cytotoxicity and anti-Trypanosoma cruzi activity.
Maia PI; Carneiro ZA; Lopes CD; Oliveira CG; Silva JS; de Albuquerque S; Hagenbach A; Gust R; Deflon VM; Abram U
Dalton Trans; 2017 Feb; 46(8):2559-2571. PubMed ID: 28154849
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
[TBL] [Abstract][Full Text] [Related]
28. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
Prast-Nielsen S; Cebula M; Pader I; Arnér ES
Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
[TBL] [Abstract][Full Text] [Related]
29. Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase.
Myers CR
Free Radic Biol Med; 2016 Feb; 91():81-92. PubMed ID: 26686468
[TBL] [Abstract][Full Text] [Related]
30. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells.
Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z
Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418
[TBL] [Abstract][Full Text] [Related]
31. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
Śmiłowicz D; Slootweg JC; Metzler-Nolte N
Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
[TBL] [Abstract][Full Text] [Related]
32. Novel triazolium based 11(th) group NHCs: synthesis, characterization and cellular response mechanisms.
Pellei M; Gandin V; Marinelli M; Orsetti A; Del Bello F; Santini C; Marzano C
Dalton Trans; 2015 Dec; 44(48):21041-52. PubMed ID: 26587827
[TBL] [Abstract][Full Text] [Related]
33. Novel antitumor adamantane-azole gold(I) complexes as potential inhibitors of thioredoxin reductase.
Garcia A; Machado RC; Grazul RM; Lopes MT; Corrêa CC; Dos Santos HF; de Almeida MV; Silva H
J Biol Inorg Chem; 2016 Apr; 21(2):275-92. PubMed ID: 26841791
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
35. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
36. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
37. Redox activation of Fe(III)-thiosemicarbazones and Fe(III)-bleomycin by thioredoxin reductase: specificity of enzymatic redox centers and analysis of reactive species formation by ESR spin trapping.
Myers JM; Cheng Q; Antholine WE; Kalyanaraman B; Filipovska A; Arnér ES; Myers CR
Free Radic Biol Med; 2013 Jul; 60():183-94. PubMed ID: 23485585
[TBL] [Abstract][Full Text] [Related]
38. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
39. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
40. Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway.
Saggioro D; Rigobello MP; Paloschi L; Folda A; Moggach SA; Parsons S; Ronconi L; Fregona D; Bindoli A
Chem Biol; 2007 Oct; 14(10):1128-39. PubMed ID: 17961825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
